Most people looking into a Mounjaro subscription have already decided the treatment might be right for them, and now want to know what committing to a monthly plan actually involves. It is a fair question, and one that many provider pages answer with a single price and a sign-up button.
This guide covers how monthly plans work in the UK, what happens to the cost as your dose changes, what a month's supply contains, and the terms worth reading before you commit.
What Mounjaro Is for Weight Loss
Mounjaro is the brand name for Mounjaro tirzepatide, made by Eli Lilly. It is a dual GIP and GLP-1 receptor agonist, acting on two gut hormone pathways rather than one. Those pathways affect appetite signalling, gastric emptying and blood glucose regulation. It helps regulate appetite, which can reduce calorie intake and support weight loss. Most people describe reduced appetite and feeling full earlier in a meal.
It is given as a weekly weight loss injection using a pre-filled pen and holds MHRA marketing authorisation for weight management alongside diet and physical activity, and separately for type 2 diabetes.
Mounjaro treatment cannot be supplied without assessment by a qualified prescriber, which is the single most important thing to understand about subscriptions. A subscription is a supply arrangement, not a way around the prescription. Treatment suitability depends on individual clinical assessment.
How Monthly Subscriptions Work
A subscription is a recurring supply arrangement. The general shape is consistent across UK providers:
- Consultation and prescriber review before anything is supplied, often completed online before supply.
- First month dispensed if approved.
- Recurring supply on a monthly cycle.
- Review at dose changes and periodically thereafter.
A subscription is a weight loss service only after clinical approval, not an automatic medicine-repeat arrangement.
The main differences between providers are in the details, and those details affect the cost
What a month's supply actually contains
Mounjaro is dosed once weekly. A month is typically four weekly doses, meaning the weekly dose of Mounjaro supplied for that month, and how those arrive depends on the pen format and dose your provider supplies.
This is worth confirming directly, because "one month's supply" is not a standardised term. Ask specifically: how many doses, delivered how often, and does the count change when my dose increases?
Some providers ship a single monthly consignment, others split shipments. Neither is wrong, but they differ for storage and for what happens if a delivery is delayed, which also affects how you store Mounjaro between delivery and use.
What's included in the plan price
| Component | Sometimes included | Worth asking |
|---|---|---|
| Medicine | Always | Which strength the quoted price covers |
| Consultation | Varies | Is the initial assessment charged separately, and could that add around £10 to £30 to the first month's cost? |
| Prescriber review at dose change | Varies | Is there a fee each time the dose increases? |
| Needles | Varies | Included or ordered separately? |
| Sharps disposal | Often not | How are used pens disposed of? |
| Delivery | Usually | Is it temperature-controlled, and is that extra? |
| Ongoing support | Varies | What support, reminders, or guides are included in the weight loss package? |
How Cost Changes Over Time
This is the part most subscription pages omit, and it is the most important thing to understand before signing up.
Treatment starts at the lowest strength. If tolerated and clinically appropriate, the dose is increased in steps under prescriber supervision. Higher strengths cost pharmacies more, and that flows through to the plan price. In private UK prescribing, mounjaro cost typically means between £120 and £340 per month.
| Stage | What's happening | Effect on monthly cost |
|---|---|---|
| Month one | Lowest starting strength | Lowest cost |
| Escalation | Stepped increases if appropriate | Rises at each step |
| Maintenance | Prescriber-determined maintenance dose or maximum maintenance dose held steady, with not everyone needing the highest level | Settles at the higher end |
| Ongoing | Continued while clinically appropriate | Recurring, indefinite |
Budgeting on the month-one price is the most common and most expensive mistake. The 2.5mg starter dose often costs £120 to £220, while later strengths can move much higher. A realistic plan is built on the maintenance figure, not the entry figure. Ask any provider directly what the plan costs at each strength, and whether the price adjusts automatically or requires a new order, because the maximum dose is not automatically the right long-term dose for every patient.
Subscription Terms Worth Reading
These questions separate providers more than headline price does:
- Can I pause? Illness, travel, supply interruptions and personal circumstances all happen. Some plans allow pausing, some only cancellation and re-signup.
- What is the cancellation notice period? Some require notice before the next billing date.
- When am I charged relative to dispatch? Charged on dispatch is safer than charged on a fixed date regardless of whether stock is available.
- What if I'm declined after paying? A prescriber may decline at initial assessment or at review. Ask about refunds explicitly.
- Does the price change automatically at dose escalation? And are you told before being charged the new amount?
- What if I have a missed dose? Ask whether that changes your review timing, whether you should skip or restart, and whether it affects the next shipment.
- Am I locked into a minimum term? Multi-month commitments reduce flexibility, and some bundle discounts carry them.
- What happens during supply constraints? Ask how they handle your next dose if escalation is delayed or stock is unavailable.
- What happens during supply constraints? See below.
Comparing UK Providers
Several UK pharmacies and online providers offer mounjaro for weight loss through subscriptions, including high-street pharmacy chains, specialist online pharmacies and online-only services. Prices differ, and there are legitimate reasons why. Manufacturer wholesale-price changes can materially affect what patients pay; for example, Eli Lilly raised wholesale prices by up to 170% in September 2025.
Purchasing terms. Volume and supplier terms vary.
Service model. A plan including prescriber time, follow-up review and packaged cold-chain delivery costs more to run than medicine-only supply. Some providers also compare Mounjaro with broader weight loss treatments, including other weight loss injections and weight loss tablets, but pricing is still best judged on like-for-like service terms.
Consumables and delivery. Small individually, meaningful annually.
Because pricing changes frequently, comparing on a snapshot published anywhere, including here, is unreliable. Check current pricing directly with each provider on the day you decide.
What to verify about any provider
- Registered with the General Pharmaceutical Council, with a number you can check on the GPhC register, because using a GPhC-registered pharmacy helps reduce the risk of counterfeit or unsafe supply of prescription medication.
- A genuine clinical assessment.
- A named prescriber accountable for the decision.
- UK-based with a physical address.
- Never offers supply without a prescription.
- Published subscription terms covering pausing, cancellation and refunds.
A price well below the market range warrants scrutiny. UK pharmacies buy the same licensed product through the same regulated supply chain, so genuine costs cluster within a fairly narrow band.
NHS Access and Eligibility
NICE recommends tirzepatide as an option for managing overweight and obesity within specific criteria.However, NHS access is different from private prescribing.NHS England is introducing tirzepatide through a phased rollout that initially prioritises people with the highest clinical need.At present, NHS access is focused on people who meet specific BMI and health criteria, with lower BMI thresholds applying for some ethnic groups. Because the rollout is being introduced in stages, many people currently receive treatment through private providers.
| NHS route | Private subscription |
|---|---|
| Cost | Prescription charge, or free if exempt |
| Eligibility | NICE criteria, typically BMI thresholds with weight-related conditions |
| Speed | Phased rollout, waits common |
| Support | NHS specialist weight management services |
If you may qualify on the NHS, speak to your GP before assuming private is the only route. Eligibility for NHS weight management treatment is based on BMI and other clinical factors, rather than personal preference alone. The NHS also publishes free weight management resources, including the NHS weight loss plan, which are worth using alongside any treatment since the trial evidence reflects medication delivered with dietary and activity support.
Supply, Storage and Delivery
Availability of GLP-1 medicines has fluctuated since launch, with demand repeatedly outstripping manufacturing capacity and specific strengths intermittently constrained.
For subscriptions this matters more than for one-off purchases, because interruptions affect continuity, and a gap in treatment can mean taking Mounjaro again at a lower dose under prescriber guidance. Ask a prospective provider how they handle supply gaps, whether they hold the strength you would escalate to next, and whether you are charged during an interruption. The MHRA and DHSC publish supply notifications when disruption is anticipated.
Mounjaro requires refrigerated storage, and the Summary of Product Characteristics sets out how the mounjaro pen should be kept, including the specific range, permitted time outside the fridge, in-use limits after first use, and the fact that you should not freeze it or use it if it has frozen.
This is why temperature-controlled delivery matters. A pen shipped in ordinary packaging in summer may have gone outside its storage range with no visible sign. Ask your provider how to store Mounjaro during travel or after a delayed delivery. Ask how your provider ships and what happens if a delivery is delayed or arrives warm.
Eligibility and the Assessment
Prescribers assess suitability using factors that commonly include BMI, weight-related health conditions, medical history, current medicines, previous weight management attempts, and baseline measurements such as body weight. Mounjaro is generally considered for adults seeking significant weight loss when clinically eligible, but everyone's weight loss journey and response can differ.
Some conditions and circumstances mean tirzepatide is not appropriate, including certain personal or family medical histories and thyroid tumour findings seen in animal studies. It is also not suitable for pregnant or breastfeeding women. Identifying these is exactly what the assessment is for, which is why full disclosure to a healthcare professional matters more than getting approved.
Being declined is not a failed transaction. It means a clinician found something making this treatment unsuitable for you, which is the process working as intended.
